BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20446291)

  • 21. Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling.
    Huang FK; Zhang G; Lawlor K; Nazarian A; Philip J; Tempst P; Dephoure N; Neubert TA
    J Proteome Res; 2017 Mar; 16(3):1121-1132. PubMed ID: 28102081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphoproteomic analysis of distinct tumor cell lines in response to nocodazole treatment.
    Nagano K; Shinkawa T; Mutoh H; Kondoh O; Morimoto S; Inomata N; Ashihara M; Ishii N; Aoki Y; Haramura M
    Proteomics; 2009 May; 9(10):2861-74. PubMed ID: 19415658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative phosphoproteomics of transforming growth factor-β signaling in colon cancer cells.
    Ali NA; Molloy MP
    Proteomics; 2011 Aug; 11(16):3390-401. PubMed ID: 21751366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Label-Free Phosphoproteomic Approach for Kinase Signaling Analysis.
    Wilkes E; Cutillas PR
    Methods Mol Biol; 2017; 1636():199-217. PubMed ID: 28730481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automatic validation of phosphopeptide identifications by the MS2/MS3 target-decoy search strategy.
    Jiang X; Han G; Feng S; Jiang X; Ye M; Yao X; Zou H
    J Proteome Res; 2008 Apr; 7(4):1640-9. PubMed ID: 18314942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics.
    Batth TS; Francavilla C; Olsen JV
    J Proteome Res; 2014 Dec; 13(12):6176-86. PubMed ID: 25338131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Phosphoproteomic Using Titanium Dioxide Micro-Columns and Label-Free Quantitation.
    Barrios-Llerena ME; Le Bihan T
    Methods Mol Biol; 2019; 1977():35-42. PubMed ID: 30980321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Label-Free Quantitative Phosphoproteomics for Algae.
    Ford MM; Lawrence SR; Werth EG; McConnell EW; Hicks LM
    Methods Mol Biol; 2020; 2139():197-211. PubMed ID: 32462588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of extracellular matrix tenascin-X detected by differential mass tagging followed by nanoLC-MALDI-TOF/TOF-MS/MS using ProteinPilot software.
    Matsumoto K
    Connect Tissue Res; 2012; 53(2):106-16. PubMed ID: 21967672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.
    Xu SG; Yan PJ; Shao ZM
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1545-56. PubMed ID: 20155427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphoproteomic analysis of mouse thymoma cells treated with tributyltin oxide: TBTO affects proliferation and energy sensing pathways.
    Osman AM; van Loveren H
    Toxicol Sci; 2012 Mar; 126(1):84-100. PubMed ID: 22174045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of liquid chromatography-tandem mass spectrometry-based targeted proteomics and conventional analytical methods for the determination of P-glycoprotein in human breast cancer cells.
    Yang T; Xu F; Xu J; Fang D; Yu Y; Chen Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 936():18-24. PubMed ID: 23968647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential Fe3O4/TiO2 enrichment for phosphopeptide analysis by liquid chromatography/tandem mass spectrometry.
    Choi S; Kim J; Cho K; Park G; Yoon JH; Park S; Yoo JS; Ryu SH; Kim YH; Kim J
    Rapid Commun Mass Spectrom; 2010 May; 24(10):1467-74. PubMed ID: 20411586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fractionation of Enriched Phosphopeptides Using pH/Acetonitrile-Gradient-Reversed-Phase Microcolumn Separation in Combination with LC-MS/MS Analysis.
    Ondrej M; Rehulka P; Rehulkova H; Kupcik R; Tichy A
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly reproducible improved label-free quantitative analysis of cellular phosphoproteome by optimization of LC-MS/MS gradient and analytical column construction.
    Ahsan N; Belmont J; Chen Z; Clifton JG; Salomon AR
    J Proteomics; 2017 Aug; 165():69-74. PubMed ID: 28634120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphoproteomic analysis provides novel insights into stress responses in Phaeodactylum tricornutum, a model diatom.
    Chen Z; Yang MK; Li CY; Wang Y; Zhang J; Wang DB; Zhang XE; Ge F
    J Proteome Res; 2014 May; 13(5):2511-23. PubMed ID: 24712722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Shotgun Phosphoproteomics Analysis.
    Carrera M; Cañas B; Lopez-Ferrer D
    Methods Mol Biol; 2021; 2259():259-268. PubMed ID: 33687721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of protein phosphorylation by monolithic extraction columns based on poly(divinylbenzene) containing embedded titanium dioxide and zirconium dioxide nano-powders.
    Rainer M; Sonderegger H; Bakry R; Huck CW; Morandell S; Huber LA; Gjerde DT; Bonn GK
    Proteomics; 2008 Nov; 8(21):4593-602. PubMed ID: 18837466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative phosphoproteomic analysis of the tumor necrosis factor pathway.
    Cantin GT; Venable JD; Cociorva D; Yates JR
    J Proteome Res; 2006 Jan; 5(1):127-34. PubMed ID: 16396503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.